Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Bisson

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Molecular Pharmacology|December 4, 2010
Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavoneIain A Murray, Colin A Flaveny, Christopher R Chiaro, et al.
Plos One|October 20, 2010
The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptorEdmond F O'Donnell, Katerine S Saili, Daniel C Koch, et al.
Blood|April 22, 2020
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasmsSunil K Joshi, Kristin Qian, William H Bisson, et al.
Nature Chemistry|March 30, 2023
OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissuesLei G Wang, Antonio R Montaño, Jason R Combs, et al.
European Journal of Medicinal Chemistry|June 6, 2022
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinaseLuca Mologni, Alexandre Orsato, Alfonso Zambon, et al.
Nature Chemistry|April 28, 2023
Publisher Correction: OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissuesLei G Wang, Antonio R Montaño, Jason R Combs, et al.
Nature Communications|December 17, 2015
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunctionChangtao Jiang, Cen Xie, Ying Lv, et al.
ACS Omega|July 5, 2022
Correction to "Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase"Luca Mologni, Sébastien Tardy, Alfonso Zambon, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 10, 2017
Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future DirectionsLuai R Zarour, Sudarshan Anand, Kevin G Billingsley, et al.
Nature Medicine|November 7, 2018
Gut microbiota and intestinal FXR mediate the clinical benefits of metforminLulu Sun, Cen Xie, Guang Wang, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Molecular Pharmacology|December 4, 2010
Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavoneIain A Murray, Colin A Flaveny, Christopher R Chiaro, et al.
Plos One|October 20, 2010
The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptorEdmond F O'Donnell, Katerine S Saili, Daniel C Koch, et al.
Blood|April 22, 2020
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasmsSunil K Joshi, Kristin Qian, William H Bisson, et al.
Nature Chemistry|March 30, 2023
OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissuesLei G Wang, Antonio R Montaño, Jason R Combs, et al.
European Journal of Medicinal Chemistry|June 6, 2022
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinaseLuca Mologni, Alexandre Orsato, Alfonso Zambon, et al.
Nature Chemistry|April 28, 2023
Publisher Correction: OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissuesLei G Wang, Antonio R Montaño, Jason R Combs, et al.
Nature Communications|December 17, 2015
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunctionChangtao Jiang, Cen Xie, Ying Lv, et al.
ACS Omega|July 5, 2022
Correction to "Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase"Luca Mologni, Sébastien Tardy, Alfonso Zambon, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 10, 2017
Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future DirectionsLuai R Zarour, Sudarshan Anand, Kevin G Billingsley, et al.
Nature Medicine|November 7, 2018
Gut microbiota and intestinal FXR mediate the clinical benefits of metforminLulu Sun, Cen Xie, Guang Wang, et al.
Pageof 7